Erythropoietin's Role in Liver Cancer Angiogenesis
Author Information
Author(s): Ribatti D, Marzullo A, Gentile A, Longo V, Nico B, Vacca A, Dammacco F
Primary Institution: University of Bari Medical School
Hypothesis
To correlate microvascular density and erythropoietin (Epo)/Epo-receptor (EpoR) expression in endothelial and tumour cells with histopathological type in hepatocellular carcinoma (HCC).
Conclusion
Epo/EpoR levels correlate with angiogenesis and progression of patients with HCC, suggesting that Epo is an important factor in hepatic tumour angiogenesis.
Supporting Evidence
- Poorly differentiated HCC had a higher degree of vascularization than other stages.
- Epo/EpoR expression increased in parallel with the grade of malignancy.
- Microvessel density was significantly higher in poorly differentiated HCC compared to well-differentiated HCC.
Takeaway
This study found that a substance called erythropoietin helps blood vessels grow in liver cancer, which might make the cancer worse.
Methodology
Immunohistochemical analysis of Epo/EpoR expression in HCC tissues from 50 patients who underwent hepatectomy.
Limitations
The study only included patients who had undergone curative hepatectomy, which may limit the generalizability of the findings.
Participant Demographics
26 males and 24 females, mean age 61 ± 5 years, range 22–75.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website